Quarterly report pursuant to Section 13 or 15(d)

Warrants - Additional Information (Details)

v3.22.2.2
Warrants - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 6 Months Ended
Jan. 19, 2022
Jan. 07, 2022
Feb. 22, 2021
Dec. 31, 2021
Jul. 31, 2021
Jul. 03, 2022
Jun. 30, 2021
Jan. 02, 2022
Dec. 05, 2021
Class of Warrant or Right [Line Items]                  
Proceeds from exercise of common stock warrants, net   $ 47,500       $ 52,828 $ 0    
Preferred stock, shares outstanding (in shares)           0   0  
Legacy Enovix Series D Convertible Preferred Stock                  
Class of Warrant or Right [Line Items]                  
Exercise price of warrants (in dollars per share)     $ 0.01            
Warrants outstanding (in shares)     10,160,936            
Proceeds from exercise of common stock warrants, net     $ 100            
Common Stock Warrants                  
Class of Warrant or Right [Line Items]                  
Warrants outstanding (in shares)         17,500,000        
Proceeds from exercise of common stock warrants, net       $ 77,200          
Public Warrants                  
Class of Warrant or Right [Line Items]                  
Warrants outstanding (in shares)         11,500,000 0   4,322,106  
Proceeds from exercise of common stock warrants, net $ 52,800                
Outstanding public warrant redemption price (in dollars per share)   $ 0.01              
Issuance of common stock upon exercise of common stock warrants (in shares)   4,126,466              
Warrants unexercised (in shares)   195,640              
Other receivables $ 5,300                
Private Placement Warrants                  
Class of Warrant or Right [Line Items]                  
Exercise price of warrants (in dollars per share)                 $ 11.50
Warrants outstanding (in shares)           6,000,000      
Class of warrant or right issued (in shares)         6,000,000